Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare primary liver malignancy that comprises features of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Due to the rarity of this tumor, the treatment of choice has not yet been defined. For resectable disease, liver resection is...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
3 February 2023
|
| In: |
Cancers
Year: 2023, Jahrgang: 15, Heft: 3, Pages: 1-15 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15030988 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers15030988 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/15/3/988 |
| Verfasserangaben: | Jemmy Zhao, Susann Stephan-Falkenau, Markus Schuler and Börge Arndt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1839553693 | ||
| 003 | DE-627 | ||
| 005 | 20230706215914.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230320s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15030988 |2 doi | |
| 035 | |a (DE-627)1839553693 | ||
| 035 | |a (DE-599)KXP1839553693 | ||
| 035 | |a (OCoLC)1389531203 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zhao, Jemmy |d 1994- |e VerfasserIn |0 (DE-588)128386455X |0 (DE-627)1839554126 |4 aut | |
| 245 | 1 | 0 | |a Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma |c Jemmy Zhao, Susann Stephan-Falkenau, Markus Schuler and Börge Arndt |
| 264 | 1 | |c 3 February 2023 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.03.2023 | ||
| 520 | |a Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare primary liver malignancy that comprises features of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Due to the rarity of this tumor, the treatment of choice has not yet been defined. For resectable disease, liver resection is the mainstay treatment. However, most patients relapse or display advanced disease and were not surgical candidates. Although the majority of patients are either primarily or secondarily treated in palliative intent, no guideline recommendations or prospective trial reports exist to allow reliable evaluation of debated treatment options. We review different locoregional or medical treatment options for advanced combined hepatocellular cholangiocarcinoma (cHCC-CC) in the neoadjuvant, adjuvant, or palliative setting and discuss the possibility of predictive biomarker-guided therapeutic options. | ||
| 650 | 4 | |a adjuvant treatment | |
| 650 | 4 | |a chemotherapy | |
| 650 | 4 | |a combined hepatocellular cholangiocarcinoma (cHCC-CC) | |
| 650 | 4 | |a locoregional treatment | |
| 650 | 4 | |a neoadjuvant treatment | |
| 650 | 4 | |a palliative treatment | |
| 650 | 4 | |a sorafenib | |
| 700 | 1 | |a Stephan-Falkenau, Susann |d 1971- |e VerfasserIn |0 (DE-588)121039293 |0 (DE-627)705182266 |0 (DE-576)292510195 |4 aut | |
| 700 | 1 | |a Schuler, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Arndt, Börge |d 1980- |e VerfasserIn |0 (DE-588)1023404486 |0 (DE-627)718374479 |0 (DE-576)366758578 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 15(2023), 3 vom: Feb., Artikel-ID 988, Seite 1-15 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:3 |g month:02 |g elocationid:988 |g pages:1-15 |g extent:15 |a Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers15030988 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/15/3/988 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230320 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 128386455X |a Zhao, Jemmy |m 128386455X:Zhao, Jemmy |d 910000 |d 910100 |e 910000PZ128386455X |e 910100PZ128386455X |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1839553693 |e 4293172785 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"part":{"year":"2023","text":"15(2023), 3 vom: Feb., Artikel-ID 988, Seite 1-15","pages":"1-15","extent":"15","volume":"15","issue":"3"},"pubHistory":["1.2009 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"614095670","disp":"Management of locally advanced or metastatic combined hepatocellular cholangiocarcinomaCancers","title":[{"title_sort":"Cancers","title":"Cancers"}],"origin":[{"dateIssuedKey":"2009","publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel"}],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 27.05.2020"]}],"id":{"eki":["1839553693"],"doi":["10.3390/cancers15030988"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"3 February 2023"}],"note":["Gesehen am 20.03.2023"],"person":[{"family":"Zhao","roleDisplay":"VerfasserIn","display":"Zhao, Jemmy","role":"aut","given":"Jemmy"},{"given":"Susann","role":"aut","display":"Stephan-Falkenau, Susann","roleDisplay":"VerfasserIn","family":"Stephan-Falkenau"},{"display":"Schuler, Markus","role":"aut","given":"Markus","family":"Schuler","roleDisplay":"VerfasserIn"},{"family":"Arndt","roleDisplay":"VerfasserIn","given":"Börge","role":"aut","display":"Arndt, Börge"}],"physDesc":[{"extent":"15 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["Jemmy Zhao, Susann Stephan-Falkenau, Markus Schuler and Börge Arndt"]},"title":[{"title_sort":"Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma","title":"Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma"}],"recId":"1839553693"} | ||
| SRT | |a ZHAOJEMMYSMANAGEMENT3202 | ||